Validation of [18F]-Sodium Fluoride as a Marker of Active Calcification and High-Risk Carotid Plaque: A Sub-study of the Canadian Atherosclerosis Imaging Network (CAIN-2)

[18F]-氟化钠作为活动性钙化和高风险颈动脉斑块标志物的验证：加拿大动脉粥样硬化成像网络 (CAIN-2) 的子研究

• 批准号: 331959
• 负责人: Cocker Myra S
• 金额: $ 0.09万
• 依托单位: University of Ottawa Heart Institute
• 依托单位国家: 加拿大
• 财政年份: 2015
• 资助国家: 加拿大
• 起止时间: 2015-05-01 至 2016-05-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=331959&lang=en
• 关键词: [18f]-Fluorodeoxyglucose Imaging; [18f]-Sodium Fluoride Imaging; Atherosclerosis; Calcification; Cardiology; Computed Tomography; Imaging; Inflammation; Positron Emission Tomography; Vulnerable Plaque

Overview: Atherosclerosis is a leading cause of mortality and morbidity in Canada. It is a disease of blood vessels or arteries where fat and cholesterol deposits accumulate on the surface of arteries forming what are known as plaques. A plaque may limit

概述： 在加拿大，动脉粥样硬化是死亡和发病的主要原因。它是一种血管或动脉疾病，其中脂肪和胆固醇沉积在动脉表面形成所谓的斑块。一个斑块可能会限制